Chemours had its Relative Strength (RS) Rating upgraded from 80 to 84 Tuesday.
Looking For The Best Stocks To Buy And Watch? Start Here
IBD's proprietary RS Rating tracks market leadership by using a 1 (worst) to 99 (best) score that indicates how a stock's price performance over the last 52 weeks matches up against the rest of the market.
Decades of market research reveals that the market's biggest winners typically have an 80 or higher RS Rating in the early stages of their moves.
While it's not currently an ideal time to invest, see if the stock is able to form a base and break out.
In terms of fundamentals, Chemours has posted two quarters of accelerating earnings growth. Revenue growth has also risen over the same time frame.
The company earns the No. 10 rank among its peers in the Chemicals-Specialty industry group. Solaris Energy Infr, Perimeter Solutions and NewMarket are among the top 5 highly rated stocks within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
Which Stocks Are Showing Rising Relative Strength?
